Clear Creek Financial Management LLC Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Clear Creek Financial Management LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 9.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,737 shares of the healthcare conglomerate’s stock after acquiring an additional 153 shares during the period. Clear Creek Financial Management LLC’s holdings in UnitedHealth Group were worth $910,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Geode Capital Management LLC boosted its stake in UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock worth $10,068,869,000 after purchasing an additional 319,515 shares during the period. Capital International Investors boosted its stake in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after buying an additional 906,365 shares during the period. Norges Bank acquired a new position in UnitedHealth Group in the 4th quarter valued at about $6,375,744,000. Northern Trust Corp lifted its position in UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares during the period. Finally, Franklin Resources Inc. raised its stake in shares of UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock worth $4,514,178,000 after purchasing an additional 861,854 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director directly owned 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $325.83 on Wednesday. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The stock has a market cap of $295.57 billion, a PE ratio of 13.64, a price-to-earnings-growth ratio of 1.48 and a beta of 0.45. The business’s fifty day moving average price is $331.91 and its two-hundred day moving average price is $451.20. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the previous year, the firm posted $6.91 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.71%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Wall Street Analyst Weigh In

A number of brokerages have commented on UNH. Royal Bank Of Canada cut their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. Wells Fargo & Company restated an “overweight” rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. KeyCorp decreased their price target on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a research note on Monday, June 2nd. Finally, TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $415.57.

View Our Latest Analysis on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading